Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
537.3 USD | -0.45% | +1.10% | +13.93% |
26/04 | HCA beats first-quarter profit estimates on higher patient admissions | RE |
25/04 | Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing | MT |
Sales 2024 * | 172B 14,305B | Sales 2025 * | 182B 15,206B | Capitalization | 125B 10,411B |
---|---|---|---|---|---|
Net income 2024 * | 8.04B 671B | Net income 2025 * | 9.06B 755B | EV / Sales 2024 * | 0.83 x |
Net Debt 2024 * | 17.19B 1,433B | Net Debt 2025 * | 12.73B 1,062B | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
13.7
x | Employees | 1,04,900 |
Yield 2024 * |
1.16% | Yield 2025 * |
1.25% | Free-Float | 99.55% |
Latest transcript on Elevance Health, Inc.
1 day | -0.45% | ||
1 week | +1.10% | ||
Current month | +3.61% | ||
1 month | +3.87% | ||
3 months | +11.05% | ||
6 months | +19.45% | ||
Current year | +13.93% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20/17/20 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 06/23/06 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | 05/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 01/13/01 | |
Director/Board Member | 55 | 01/22/01 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20/17/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 18 M€ | +3.79% | - | |
2.36% | 1,026 M€ | +6.95% | - | |
2.07% | 8 M€ | +2.44% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 537.3 | -0.45% | 700,726 |
25/24/25 | 539.7 | +1.11% | 1,066,975 |
24/24/24 | 533.7 | +0.15% | 916,012 |
23/24/23 | 532.9 | +0.13% | 811,682 |
22/24/22 | 532.2 | +0.15% | 1,525,124 |
Delayed Quote Nyse, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.93% | 125B | |
+18.37% | 101B | |
-0.28% | 39.69B | |
-33.18% | 36.86B | |
-5.28% | 20.05B | |
-13.82% | 3.08B | |
-39.49% | 993M | |
-28.58% | 337M |
- Stock Market
- Equities
- ELV Stock